Aprecia Pharmaceuticals

22 articles about Aprecia Pharmaceuticals

• Aprecia and Battelle Are Impacting The Pharmaceutical Industry Through 3D Printing Innovation

  11/15/2023

  Aprecia, a precision drug delivery company, has partnered with the research and development experts at Battelle to develop groundbreaking 3D printing platforms with the potential to transform the way medicines are developed, manufactured, distributed, and administered.

• Aprecia Names Industry Leader Owen Murray as Its CEO

  1/30/2023

  Aprecia Pharmaceuticals today announced Owen Murray as its Chief Executive Officer.

• 

  In Leap Forward, Triastek Takes 3D-Printed Cardiovascular Drug into the Clinic

  4/8/2022

  The U.S. FDA greenlit China-based Triastek's IND Application for its 3D printed drug product, T20, for cardiovascular and clotting disorders.

• Aprecia Selects Garry Hedgepeth to Lead Quality Team

  3/8/2022

  Aprecia Pharmaceuticals announced that it has hired Garry Hedgepeth as Vice President of Quality.

• Purdue University and US Pharmacopeia Launch Webinar Series on Pharmaceutical 3D-Printing

  8/4/2021

  Purdue University, in partnership with US Pharmacopeia and sponsorship from Aprecia Pharmaceuticals, LLC, announced a new pharmaceutical industry technology forum focused on 3D-Printing pharmaceutical medications and the benefits to patients, pharmaceutical executives, formulation scientists, and compounding pharmacists.

• Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines

  4/21/2021

  Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms.

• Aprecia Establishes a Long-Term Partnership with Battelle

  12/21/2020

  Battelle's innovative design teams will focus on expanding the capabilities of Aprecia's 3DP technology platform addressing important pharmaceutical product challenges through 3DP innovation

• 3D pharmaceutical printing is the focus of Aprecia-Purdue partnership

  2/20/2020

  WEST LAFAYETTE, Ind. and CINCINNATI , Feb. 20, 2020 /PRNewswire/ -- Healthcare is poised for a potential giant leap forward thanks to the 3D printing of medications.   To advance the technology and science of 3D pharmaceutical printing, Purdue University's College of Pharmacy and Aprecia Pharmaceuticals, LLC are launching a comprehensive collaboration on future 3DP pharmaceu

• Kirk Donaldson joins Aprecia to Lead Global Business Development

  9/5/2019

  Donaldson's partnering expertise to accelerate the implementation of Aprecia's Business Development strategy

• Aprecia Names Chris Gilmore Chief Executive Officer

  4/17/2019

  Aprecia, the 3DP Pharmaceutical Company, today announced that Chris Gilmore has been named the company's Chief Executive Officer.

• Aprecia and CMIC, a Leading CDMO in Japan, have established an agreement to bring 3DP pharmaceutical products to Japan

  3/7/2019

  Leading Japanese pharma value creator to lead Aprecia's Business Development in Japan

• Aprecia and Cycle Partner to Develop 3D-Printed Orphan Drugs

  12/12/2017

  The planned products will deliver quality-of-life improvements versus existing, approved orphan drugs, and will achieve this by utilizing Aprecia's proprietary 3DP ZipDose Technology platform.

• Aprecia Pharma Names University of Kentucky Provost as the Company's Next CEO

  11/1/2017

  Aprecia Pharma announced today that Dr. Timothy Tracy will serve as the company's next CEO, beginning in January 2018.

• Prasco Laboratories Affiliate Acquires Larger Stake In Aprecia

  9/7/2017

• Aprecia Secures Up To $30 Million From Hercules Capital

  7/5/2016

• Aprecia Release: First FDA-Approved Medicine Manufactured Using 3d Printing Technology Now Available

  3/22/2016

• Aprecia Set To Advance 3D Printed Drug Pipeline With Completion Of $35 Million Financing Led By Deerfield Management

  1/27/2016

• FDA Green Lights First 3D Printed Drug From Aprecia

  8/6/2015

• Aprecia Pharmaceuticals to Fill Vacant Building With 150 Jobs, $25 Million Investment

  2/25/2015

• Aprecia Pharmaceuticals Receives FDA Acceptance For Filing For First Product Using Advanced Zipdose® Technology

  12/9/2014